BNP Paribas Exane Begins Coverage on Vylor (NYSE:VYLR)

Equities research analysts at BNP Paribas Exane initiated coverage on shares of Vylor (NYSE:VYLR) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The firm set a “hold” rating and a $75.00 price target on the stock. BNP Paribas Exane’s price target points to a potential upside of 1.76% from the stock’s previous close.

Several other research firms have also recently weighed in on VYLR. The Goldman Sachs Group began coverage on shares of Vylor in a report on Thursday, October 8th. They set a “buy” rating and a $87.00 price objective for the company. Deutsche Bank Aktiengesellschaft began coverage on shares of Vylor in a research report on Wednesday. They set a “buy” rating and a $90.00 target price on the stock. UBS Group assumed coverage on shares of Vylor in a research note on Monday. They issued a “buy” rating and a $89.00 target price for the company. Oppenheimer started coverage on shares of Vylor in a report on Tuesday, October 6th. They issued an “outperform” rating and a $82.00 price objective for the company. Finally, Zacks Research upgraded Vylor to a “hold” rating in a report on Monday, October 5th. Three investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $82.67.

Vylor Stock Down 0.9%

VYLR traded down $0.70 during midday trading on Wednesday, reaching $73.70. 95,360 shares of the company’s stock traded hands, compared to its average volume of 7,204,730. Vylor has a 52 week low of $65.00 and a 52 week high of $77.39.

About Vylor

Vylor Inc is a seed and genetics company. It develops and supplies germplasm for farmers to improve crop health and produce higher yields. Vylor Inc is based in JOHNSTON, Iowa.